Next |
home / stock / pyxs / pyxs message board
Subject | By | Source | When |
---|---|---|---|
I did, nice P&D | TheFinalCD | investorshub | 04/10/2023 12:15:10 AM |
Wouldn't touch it until we see if that | SpaceTimeRift777 | investorshub | 04/05/2023 12:40:01 PM |
Perfect example of dilution,in other words a classic | spencer22 | investorshub | 04/04/2023 11:19:03 AM |
7). https://finviz.com/quote.ashx?t=$PYXS&p=d$10.75 PYX | 0210 | investorshub | 03/31/2023 9:23:02 PM |
buyin' dips $4.00 - $4.10. https://ih.advfn.com/stock-market/NASDAQ/pyxis-oncology-$PYXS/tr | 0210 | investorshub | 03/31/2023 8:42:02 PM |
I just heard the same thing from a | interloper | investorshub | 03/31/2023 5:24:41 PM |
That dip was a gift. Loaded way oversold. | Jess070283 | investorshub | 03/31/2023 2:22:03 PM |
potential halt at $2. seems to be fair value | magacrew2020 | investorshub | 03/31/2023 2:17:32 PM |
#$PYXS ?? big squeeze coming??!! Attractive bullish chart! $PYXS https://youtu.be | da_stock_analyst | investorshub | 03/31/2023 1:16:37 AM |
* * > $7 halt < * * | Pyramid2 | investorshub | 03/30/2023 8:43:48 PM |
Better lock profits today this will come back | SpaceTimeRift777 | investorshub | 03/30/2023 5:56:48 PM |
One hell of a Moon Market pump | SpaceTimeRift777 | investorshub | 03/30/2023 5:09:05 PM |
Please post something that you have proof. You | jakec21 | investorshub | 03/30/2023 5:02:16 PM |
$PYXS....MONSTER TAKING OFF!! | TrendTrade2016 | investorshub | 03/30/2023 3:53:19 PM |
Thorough DD is how I found my info | PickItToWin | investorshub | 03/30/2023 3:13:03 PM |
It's from a tiktok video... | eastunder | investorshub | 03/30/2023 1:13:36 PM |
#$PYXS ?? can it double from here? very | da_stock_analyst | investorshub | 03/29/2023 10:58:14 PM |
hmmmm, any info or articles to back your | TheFinalCD | investorshub | 03/29/2023 10:18:55 PM |
Beast!$$$ | Jess070283 | investorshub | 03/29/2023 9:00:30 PM |
Yea what a joke | Randyfloyd420 | investorshub | 03/29/2023 12:32:54 AM |
News, Short Squeeze, Breakout and More Instantly...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effecti...
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a...
PYX-201 Phase 1 trial clinical readout on track for fall of 2024 Executive Leadership Team expanded with the appointment of Stephen Worsley as Senior Vice President, Chief Business Officer PYX-106 Phase 1 trial clinical readout on track for 2H 2024 Expected cash runway i...